Roche Pharma | The Tamiflu Fraud
In 1999, the FDA approved Tamiflu for the treatment & prevention of Influenza. In 2020, a Federal Judge denied Roche's motion to dismiss a $1.5 Billion Fraud suit. But, Roche is at it again!
Brief Background
On October 27th, 1999 the FDA approved Roche’s new antiviral drug Tamiflu (Oseltamivir) for the ‘treatment and prevention’ of Influenza.
Based on unpublished trial results, Roche made …
Keep reading with a 7-day free trial
Subscribe to Remnant | MD to keep reading this post and get 7 days of free access to the full post archives.